Showing papers in "Current Problems in Cancer in 2010"
••
TL;DR: The most frequently used names, trabecular carcinoma of the skin, cutaneous neuroendocrine carcinoma, and MCC, correspond to the sequential acquisition of knowledge on the cellular origin of this cancer.
171 citations
••
TL;DR: Procedure Appropriateness Category Relative Radiation Level Arteriography cerebral Usually Not Appropriate CTA head with IV contrast Usually not Appropriate MRA head without and with IV Contrast UsuallyNot Appropriate O MRA heads without and without IV contrast usually Not Appropriated O Radiography skull Usuallynot Appropriate.
58 citations
••
35 citations
••
TL;DR: Cardiac screening with echocardiogram and exercise tolerance tests in patients with history of mediastinal irradiation and/or adriamycin exposure may be appropriate, although the optimal screening interval would depend on mediationastinal dose, adriamicin dose, presence of other cardiac risk factors and findings at the baseline screening.
30 citations
••
TL;DR: Since aggressive local therapy is beneficial for survival, local control and quality of life, the use of these various treatment modalities needs to be carefully investigated given the growing number of long-term survivors.
29 citations
••
TL;DR: Increly sophisticated pathologic assessments and the elucidation of molecular markers, such as the human papilloma virus (HPV), in sinonasal cancers have the potential to transform the clinical management of these malignant neoplasms.
26 citations
••
25 citations
••
24 citations
••
22 citations
••
21 citations
••
TL;DR: An expert panel designated by the American College of Radiology has reviewed supporting data, from a few prospective multi-institutional trials and a number of single-institution, retrospective reviews, and recognizes the importance of accurate staging to identify patients who may be candidates for a local excision approach.
••
TL;DR: In this article, a review summarizes the current literature on metastatic colorectal cancer (CRC) and presents 4 simulated patient variants, including resectable liver or lung metastases and no evidence of any extrahepatic metastases.
••
TL;DR: There is a clear paucity of data supporting the use of chemotherapy in the adjuvant setting for Merkel Cell Carcinoma (MCC), and there is a great deal of variability between those with micrometastatic disease to a sentinel lymph node and those with bulky nodal replacement from MCC, which makes designing appropriate and well-powered adjUvant chemotherapy trials in MCC very difficult.
••
TL;DR: Treatment consensus derived from the modified Delphi methodology is provided for resectable oropharyngeal squamous cell carcinomas.
••